SGX Market Updates

Singapore’s 10 Most Traded Healthcare Stocks in Early 2020


PUBLISHED ON |

12 February 2020

  • Since the end of 2019, the Health Sector has been the second strongest segment of the global stock market, closely following the performance of the Tech Sector. Health Stocks make up approximately 10 per cent of global market capitalisation.

  • Singapore’s 10 most traded Health Stocks in the 2020 year to 11 Feb averaged S$26 million a day in combined turnover, while generating 13% median gains and average gains of 36%. The same 10 stocks averaged S$7 million daily turnover and a decline of 1% in 2019.

  • The 3 most traded Singapore healthcare-related stocks in the 2020 year to 11 Feb, include Medtecs International, First REIT & UG Healthcare. Medtecs International and UG Healthcare have also been amongst the strongest performers of Singapore’s health care stocks for the period.




Healthcare stocks across Asia Pacific have begun 2020 on a firm defensive note with the caution and concerns on the outbreak of the Covid-19 Coronavirus in China.

There are between 1,500 and 2,000 healthcare-related stocks listed across the Asia Pacific. These stocks have generated median gains of 3%, with an average return of 8% for the 2020 year through to 11 February. Globally, the Healthcare Sector has been the second best performer in early 2020, closely following the returns of the Technology Sector, whilst the Energy Sector was been the least performer.

In Singapore, the Healthcare Sector, as represented by the iEdge SG All Healthcare Index, has also generated an 8% total return in the 2020 year through to 11 February. The 10 most traded Healthcare-related stocks ranked by turnover in the 2020 year through to 11 February, which are also a part of the iEdge SG All Healthcare Index, are tabled below.

Stock SGX
Code
Market
Cap
S$m
Total
Return
2020 YTD
%
Total
Return
2019
%
30 Day Ann
Volatility
%
Biggest Revenue
source in
Most Recent
Annual Report
P/E Average
Daily
Turnover
S$M
Medtecs Intl 546 60 197 37 325 Manufacturing 47 12.13
First REIT AW9U 796 2 10 11 Indonesia Properties 17 2.54
UG Healthcare 41A 54 96 -34 305 Latex Examination Gloves 31 2.22
Raffles Medical BSL 1,883 3 -7 25 Hospital Services 29 2.19
ParkwayLife REIT C2PU 2,172 9 32 21 Healthcare Property 14 1.44
Clearbridge 1H3 96 20 -17 49 Laboratory testing N/A 1.33
Riverstone AP4 800 17 -17 70 Gloves 18 1.29
Thomson Medical A50 1,586 -6 -12 31 Hospital Ops & Ancillary Serv. N/A 1.06
Healthway Med 5NG 149 27 -19 152 Primary Healthcare N/A 0.96
Haw Par H02 2,708 -4 15 11 Healthcare Products 14 0.65
Median     13.0 -9.4        
Average     36.2 -1.2        

Source: SGX StockFacts, Thomson Reuters, Bloomberg (Data as of 12 February 2020), note First REIT and ParkwayLife REIT total returns include dividend distributions.



Of the 10 stocks tabled above, the three stocks that generated the strongest volatility-adjusted returns in 2020 through to 11 February included Medtecs International, ParkwayLife REIT and Clearbridge Health.

The 10 most traded healthcare stocks for the 2020 year through to 11 February have seen combined turnover of S$26 million with S$35 million of net retail inflows. The average daily turnover for these 10 stocks is up close to threefold, from S$7 million in 2019. Four of the 10 stocks, Medtecs International, UG Healthcare, Clearbridge Health and Healthway Medical Group are listed on the Catalist board.

The 10 stocks tabled above also maintain valuations in-line with regional peers. Across Asia Pacific, the median Price-to-Earnings (P/E) ratio for the 70% of Healthcare stocks that maintained positive earnings is 24x. Similarly, the 7 of the 10 stocks tabled above with P/E ratios average a ratio of 23x.

Top Glove Corporation, which has averaged S$522k in daily turnover in the 2020 year to date, was the next most traded Healthcare stock outside of the 10 stocks tabled above. The leading manufacturer of disposable rubber gloves has generated a 24% price gain over the period, following on from a decline in total return of 14% in 2019. IHH Healthcare by comparison has averaged a 3% gain in the early 2020 year, following on from a 4% total return in 2019.

First REIT and ParkwayLife REIT recently reported their FY19 results. ParkwayLife REIT (click here) reported a 2.5% increase in its FY19 distribution per unit (“DPU”), whilst First REIT (click here) maintain the same DPU in FY19 as FY18. ParkwayLife REIT has a portfolio of 53 quality healthcare and healthcare-related properties in Singapore, Japan and Malaysia, while First REIT’s portfolio consists of 20 properties located in Indonesia, Singapore and South Korea.







This article is provided by SGX My Gateway.



SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.












Stock / REIT Search

Advertisement

Advertisement